In today’s episode we have updates which include approval of Opzelura a new topical treatment for atopic dermatitis, and approval of Qulipta for migraine prevention. We'll also be going over approval of Livmarli for symptoms in patients with Alagille syndrome - also known as ALGS). Don't forget to like, share and subscribe, and ENJOY!